It has been demonstrated that most NMO-IgGs preferentially bind to AQP4 incorporated into OAPs, although the primary sequence of the extracellular region between M1 and M23 is the same [90,92,95,96,98]. The gene discussed is AQP4; the disease is neuromyelitis optica.